Logo

Sana Biotechnology, Inc.

SANA

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295 and SG242 that… read more

Healthcare

Biotechnology

2 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$3.72

Price

+4.65%

$0.17

Market Cap

$882.300m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$15.282m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$252.182m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.06

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$122.556m

$361.645m

Assets

$239.089m

Liabilities

$85.492m

Debt
Debt to Assets

23.6%

-0.3x

Debt to EBITDA
Free Cash Flow

-$185.291m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases